Daruka Mahadevan
- Molecular Biology top 10%
- Hematology top 1%
- Genetics top 1%
- Oncology top 5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Alan F. ListDeborah FuchsRobert KnightS. KurtinLisa M. RimszaJerome B. ZeldisDenise J. RoeRuth Heaton
- Topics
- Chronic Lymphocytic Leukemia Research (33 papers)Lymphoma Diagnosis and Treatment (19 papers)Monoclonal and Polyclonal Antibodies Research (15 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Daruka Mahadevan
68 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 834
- Hematology 693
- Genetics 680
- Oncology 634
- Pathology and Forensic Medicine 574
Countries citing papers authored by Daruka Mahadevan
This map shows the geographic impact of Daruka Mahadevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daruka Mahadevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daruka Mahadevan more than expected).
Fields of papers citing papers by Daruka Mahadevan
This network shows the impact of papers produced by Daruka Mahadevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daruka Mahadevan. The network helps show where Daruka Mahadevan may publish in the future.
Co-authorship network of co-authors of Daruka Mahadevan
This figure shows the co-authorship network connecting the top 25 collaborators of Daruka Mahadevan. A scholar is included among the top collaborators of Daruka Mahadevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daruka Mahadevan. Daruka Mahadevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 24 | |
| 4 | 63 | |
| 5 | 15 | |
| 6 | 61 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 5 | |
| 10 | 44 | |
| 11 | 161 | |
| 12 | 39 | |
| 13 | 36 | |
| 14 | 21 | |
| 15 | 26 | |
| 16 | 19 | |
| 17 | Efficacy of Lenalidomide in Myelodysplastic Syndromesbreakdown → | 613 |
| 18 | 47 | |
| 19 | 22 | |
| 20 | 14 |
About Daruka Mahadevan
Daruka Mahadevan is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 70 papers that have together received 2.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (19 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). The work is most often cited by research in Genetics (680 citations), Hematology (693 citations) and Pathology and Forensic Medicine (574 citations). Daruka Mahadevan has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Alan F. List, Deborah Fuchs, Robert Knight, S. Kurtin, Lisa M. Rimsza, Jerome B. Zeldis, Denise J. Roe, Ruth Heaton, Richard I. Fisher and Laurence Cooke. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.